564 related articles for article (PubMed ID: 9237990)
1. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes.
Wang M; Roberts DL; Paschke R; Shea TM; Masters BS; Kim JJ
Proc Natl Acad Sci U S A; 1997 Aug; 94(16):8411-6. PubMed ID: 9237990
[TBL] [Abstract][Full Text] [Related]
2. Four crystal structures of the 60 kDa flavoprotein monomer of the sulfite reductase indicate a disordered flavodoxin-like module.
Gruez A; Pignol D; Zeghouf M; Covès J; Fontecave M; Ferrer JL; Fontecilla-Camps JC
J Mol Biol; 2000 May; 299(1):199-212. PubMed ID: 10860732
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the FAD/NADPH-binding domain of rat neuronal nitric-oxide synthase. Comparisons with NADPH-cytochrome P450 oxidoreductase.
Zhang J; Martàsek P; Paschke R; Shea T; Siler Masters BS; Kim JJ
J Biol Chem; 2001 Oct; 276(40):37506-13. PubMed ID: 11473123
[TBL] [Abstract][Full Text] [Related]
4. The crystal structure of NADPH:ferredoxin reductase from Azotobacter vinelandii.
Sridhar Prasad G; Kresge N; Muhlberg AB; Shaw A; Jung YS; Burgess BK; Stout CD
Protein Sci; 1998 Dec; 7(12):2541-9. PubMed ID: 9865948
[TBL] [Abstract][Full Text] [Related]
5. The domain architecture of cytochrome P450BM-3.
Govindaraj S; Poulos TL
J Biol Chem; 1997 Mar; 272(12):7915-21. PubMed ID: 9065459
[TBL] [Abstract][Full Text] [Related]
6. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
Yamamoto K; Kimura S; Shiro Y; Iyanagi T
Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
[TBL] [Abstract][Full Text] [Related]
7. Determination of the redox potentials and electron transfer properties of the FAD- and FMN-binding domains of the human oxidoreductase NR1.
Finn RD; Basran J; Roitel O; Wolf CR; Munro AW; Paine MJ; Scrutton NS
Eur J Biochem; 2003 Mar; 270(6):1164-75. PubMed ID: 12631275
[TBL] [Abstract][Full Text] [Related]
8. Determination of the redox properties of human NADPH-cytochrome P450 reductase.
Munro AW; Noble MA; Robledo L; Daff SN; Chapman SK
Biochemistry; 2001 Feb; 40(7):1956-63. PubMed ID: 11329262
[TBL] [Abstract][Full Text] [Related]
9. Coupling of Redox and Structural States in Cytochrome P450 Reductase Studied by Molecular Dynamics Simulation.
Iijima M; Ohnuki J; Sato T; Sugishima M; Takano M
Sci Rep; 2019 Jun; 9(1):9341. PubMed ID: 31249341
[TBL] [Abstract][Full Text] [Related]
10. Crystallization and preliminary x-ray studies of NADPH-cytochrome P450 reductase.
Djordjevic S; Roberts DL; Wang M; Shea T; Camitta MG; Masters BS; Kim JJ
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3214-8. PubMed ID: 7724541
[TBL] [Abstract][Full Text] [Related]
11. A 31P-nuclear-magnetic-resonance study of NADPH-cytochrome-P-450 reductase and of the Azotobacter flavodoxin/ferredoxin-NADP+ reductase complex.
Bonants PJ; Müller F; Vervoort J; Edmondson DE
Eur J Biochem; 1990 Jul; 190(3):531-7. PubMed ID: 2115440
[TBL] [Abstract][Full Text] [Related]
12. A second FMN binding site in yeast NADPH-cytochrome P450 reductase suggests a mechanism of electron transfer by diflavin reductases.
Lamb DC; Kim Y; Yermalitskaya LV; Yermalitsky VN; Lepesheva GI; Kelly SL; Waterman MR; Podust LM
Structure; 2006 Jan; 14(1):51-61. PubMed ID: 16407065
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the FMN-binding domain of human cytochrome P450 reductase at 1.93 A resolution.
Zhao Q; Modi S; Smith G; Paine M; McDonagh PD; Wolf CR; Tew D; Lian LY; Roberts GC; Driessen HP
Protein Sci; 1999 Feb; 8(2):298-306. PubMed ID: 10048323
[TBL] [Abstract][Full Text] [Related]
14. Relaxation kinetics of cytochrome P450 reductase: internal electron transfer is limited by conformational change and regulated by coenzyme binding.
Gutierrez A; Paine M; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2002 Apr; 41(14):4626-37. PubMed ID: 11926825
[TBL] [Abstract][Full Text] [Related]
15. NADPH-cytochrome P-450 oxidoreductase: flavin mononucleotide and flavin adenine dinucleotide domains evolved from different flavoproteins.
Porter TD; Kasper CB
Biochemistry; 1986 Apr; 25(7):1682-7. PubMed ID: 3085707
[TBL] [Abstract][Full Text] [Related]
16. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of coenzyme binding to human methionine synthase reductase revealed through the crystal structure of the FNR-like module and isothermal titration calorimetry.
Wolthers KR; Lou X; Toogood HS; Leys D; Scrutton NS
Biochemistry; 2007 Oct; 46(42):11833-44. PubMed ID: 17892308
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
19. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
20. Location of functional centers in the microsomal cytochrome P450 system.
Centeno F; Gutiérrez-Merino C
Biochemistry; 1992 Sep; 31(36):8473-81. PubMed ID: 1390631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
